• 11jun
    A view from the Bench (by Barbara Vanhoecke)
    X Pure News

    A view from the Bench (by Barbara Vanhoecke)

    This article is taken from European Biopharmaceutical Review July 2019, pages 38-40. © Samedan Ltd. ­    A new approach to remove endotoxins should be considered to ease the job of selecting the right base material for biomedical applications. Choosing the right base material for bioengineering is ...

  • 9may
    Rousselot® highlights new cell viability study on X-PURE® at Bioconvention 2019
    Categories: X Pure News

    Rousselot® highlights new cell viability study on X-PURE® at Bioconvention 2019

    Rousselot®, booth 326, Bioconvention, Philadelphia, PA, United States, 03 – 06 June 2019. Rousselot®  will highlight new research on its X-Pure® range at this year’s Bioconvention. As intensely purified medical grade gelatins and collagens, X-Pure has shown huge potential in biomedical applications ...

  • 14feb
    Rousselot inaugurates  a State-of-the-Art Pilot Hall in Ghent
    Categories: X Pure News

    Rousselot inaugurates a State-of-the-Art Pilot Hall in Ghent

    Son, February 14, 2019 To respond to the needs of our fast-moving world and ensure the long-term success of our company, Rousselot has put innovation at the heart of its development strategy. Supporting this strategy, the new Pilot Hall inaugurated on February 14th, comes with the most modern and ...

  • 16may
    With X-PURE®, Rousselot sets a new gelatin standard for in-body applications
    Categories: News , X Pure News

    With X-PURE®, Rousselot sets a new gelatin standard for in-body applications

    Son, Netherlands – May 16th, 2018 - Rousselot, the world leading producer of gelatin and collagen peptides, today launches a new medical grade gelatin range, X-Pure®, with outstanding levels of purity for in-body applications. Visitors at the Bio International Convention in Boston can find out more ...

  • 1